PharmaBioSource Realty provided real estate services to Genmab on the sale of its 215,000 SF Brooklyn Park, Minnesota mammalian cell culture biologics drug substance facility to Baxter.

• Service: Real Estate
• Sector: Biotechnology
• Sub-sector: Mammalian Cell Culture Drug Substance
• Engagement Type: Sell Side

PharmaBioSource Realty provided exclusive life sciences real estate services to divest Genmab’s mammalian cell culture drug substance facility near Minneapolis. The facility houses 2 x 20,000L and 2 x 1,000L bioreactors with associated downstream suites, QC laboratories, offices and GMP warehouse space.

PharmaBioSource Realty’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support. 

Press Release